Life Sciences

The research in the Life Sciences category spans a wide range of sectors related to, and driven by, the biological sciences. This range runs from basic laboratory research tools and services through applications in medicine, agriculture, and even some aspects of environmental and materials sectors. Our market research reports cover the Biotechnology, Pharmaceuticals, Diagnostics, Healthcare, and Medical Devices industries, offering in-depth analysis of markets, trends, and competitors.

By far the biggest industries in the life sciences category are related to human healthcare, including pharmaceuticals; diagnostics; medical devices; and healthcare facilities, delivery, policy and financing. Although heavily regulated in most parts of the globe, human healthcare continues to be a high-growth and often high-margin sector driven by technological innovation, ever-increasing demand, and well-developed funding and public sector support. It is not unusual for breakthrough products in this sector to experience explosive double- and triple-digit growth in their early years, and even products and services that are mere commodities in other markets can find premium value when associated with clinical applications. Despite this luring promise, the complex regulatory, technological, and financial dynamics of this sector make it one of the most challenging to manufacturers and marketers.
Page 2/28
Category Tools

Generics in Asia-Pacific

August 2013 · MarketLine Generics in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in South Africa

August 2013 · MarketLine OTC Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Global OTC Pharmaceuticals

August 2013 · MarketLine Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in China

August 2013 · MarketLine Generics in China industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Canada

August 2013 · MarketLine OTC Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Pet Care in Asia-Pacific

August 2013 · MarketLine Pet Care in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in Germany

August 2013 · MarketLine Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in France

August 2013 · MarketLine OTC Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Pet Care in Germany

August 2013 · MarketLine Pet Care in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in Spain

August 2013 · MarketLine Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Singapore

August 2013 · MarketLine OTC Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Spain

August 2013 · MarketLine OTC Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Pet Care in the United Kingdom

August 2013 · MarketLine Pet Care in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Japan

August 2013 · MarketLine OTC Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in India

August 2013 · MarketLine OTC Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Biotechnology in Asia-Pacific

August 2013 · MarketLine Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

Generics in the United States

August 2013 · MarketLine Generics in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2007-11, and forecast to 2016). € 259,00

Biotechnology in China

August 2013 · MarketLine Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

Health Care Equipment & Supplies: Global Industry Guide

August 2013 · MarketLine Global Health Care Equipment & Supplies industry guide provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 749,00

Abbott Laboratories - SWOT, Strategy and Corporate Finance Report

July 2013 · MarketLine Abbott Laboratories - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

F. Hoffmann-La Roche Ltd - SWOT, Strategy and Corporate Finance Report

July 2013 · MarketLine F. Hoffmann-La Roche Ltd - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Apotex, Inc. - SWOT, Strategy and Corporate Finance Report

July 2013 · MarketLine Apotex, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

AAIPharma Services Corporation - SWOT, Strategy and Corporate Finance Report

July 2013 · MarketLine AAIPharma Services Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Sanofi - SWOT, Strategy and Corporate Finance Report

July 2013 · MarketLine Sanofi - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Chugai Pharmaceutical Co., Ltd. - SWOT, Strategy and Corporate Finance Report

July 2013 · MarketLine Chugai Pharmaceutical Co., Ltd. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00

Novo Nordisk A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Fresenius SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Immunocellular Therapeutics, Ltd. (formerly Optical Molecular Imaging, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Gambro AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Volcano Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Vical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Misonix, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Cephalon, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

BioWa, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Advaxis, Inc. (formerly Great Expectations & Associates, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Sun Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Cancer Research Technology Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Medline Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Dynavax Technologies Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Omeros Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Horizon Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Eurand N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

LFB S.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Fresenius Medical Care AG & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Wright Medical Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Intrexon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

BioFocus DPI plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Illumina, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Aventis SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Options